Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus

Journal of General Virology

Volumn 88, Issue 4, 2007, Pages 1324-1336

  Tagmyer, Tara L ^a   Craigo, Jodi K ^a   Cook, Sheila J ^b   Issel, Charles J ^b   Montelaro, Ronald C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LIVE VACCINE; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN GP45; VIRUS GLYCOPROTEIN GP90; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA VIRUS; HELPER CELL; HORSE; HUMORAL IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; INOCULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CELL PROLIFERATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS;

EID: 34047113368     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82391-0     Document Type: Article

References (41)

1. Albright-Fraser, D. G., Reid, R., Graber, V. & Bailey, E. (1996). Polymorphism of DRA among equids. Immunogenetics 43, 315-317.
2. Bailey, E. (11980). Identification and genetics of horse lymphocyte alloantigens. Immunogenetics 11, 499-506.
3. Bailey, E. (11983). Population studies on the ELA system in American standardbred and thoroughbred mares. Anim Blood Groups Biochem Genet 14, 201-211.
4. Ball, J. M., Rushlow, K. E., Issel, C. J. & Montelaro, R. C. (1992). Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J Virol 66, 732-742.
5. Bogers, W. M. J. M., Cheng-Mayer, C. & Montelaro, R. C. (2000). Developments in preclinical AIDS vaccine efficacy models. AIDS 14 (Suppl.), S141-S152.
6. Chung, C., Leib, S. R., Fraser, D. G., Ellis, S. A. & McGuire, T. C. (2003). Novel classical MHC I alleles identified in horses by sequencing clones of reverse transcription-PCR products. Eur J Immunogenet 30, 387-396.
7. Chung, C., Mealey, R. H. & McGuire, T. C. (2005). Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses. Virology 342, 228-239.
8. Clements, J. E., Montelaro, R. C., Zink M. C., Amedee, A. M., Miller, S., Trichel, A. M., Jagerski, B., Hauer, D., Martin, L. N. & Bohm, R. P. (1995). Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 69, 2737-2744.
9. Cole, K. S., Rowiles, J. L., Jagerski, B. A., Murphey-Corb, M., Unangst, T., Clements, J. E., Robinson, J., Wyand, M. S., Desrosiers, R. C. & Montelaro, R. C. (1997). Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 71, 5069-5079.
10. Cole, K S., Murphey-Corb, M., Narayan, O., Joag, S. V., Shaw, G. M. & Montelaro, R. C. (11998). Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J Virol 72, 7852-7859.
11. Craigo, J. K., Leroux, C., Howe, L., Steckbeck J. D., Cook S. J., Issel, C. J. & Montelaro, R. C. (2002). Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. J Gen Virol 83, 1353-1359.
12. Craigo, J. K., Li, F., Steckbeck, J. D., Durkin, S., Howe, L., Cook S. J., Issel, C. & Montelaro, R. C. (2007). Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy. J Virol 79, 2666-2677.
13. Craigo, J. K., Durkin, S., Sturgeon, T. J., Tagmyer, T., Cook, S. J., Issel, C. J. & Montelaro, R. C. (2007). Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines. Vaccine 25, 834-845.
14. Fraser, D. G. & Bailey, E. (11998). Polymorphism and multiple loci for the horse DQA gene. Immunogenetics 47, 487-490.
15. Fraser, D. G., Oaks, J. L., Brown, W. C. & McGuire, T. C. (2002). Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus. Immunology 105, 295-305.
16. Fraser, D. G., Leib, S. R., Zhang, B. S., Mealey, R. H., Brown, W. C. & McGuire, T. C. (2005). Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge. Clin Diagn Lab Immunol 12, 983-993.
17. Hammond, S. A., Cook S. J., Lichtenstein, D. L., Issel, C. J. & Montelaro, R. C. (1997). Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J Virol 71, 3840-3852.
18. Hammond, S. A., Issel, C. J. & Montelaro, R. C. (1998). General method for the detection and in vitro expansion of equine cytolytic T lymphocytes. J Immunol Methods 213, 73-85.
19. Hammond, S. A., Raabe, M. L., Issel, C. J. & Montelaro, R. C. (1999). Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology 262, 416-430.
20. Howe, L., Leroux, C., Issel, C. J. & Montelaro, R. C. (2002). Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J Virol 76, 10588-10597.
21. Hussain, K. A., Issel, C. J., Schnorr, K. L., Rwambo, P. M. & Montelaro, R. C. (1987). Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J Virol 61, 2956-2961.
22. Issel, C. J. & Coggins, L. (1979). Equine infectious anemia virus: current knowledge. J Am Vet Med Assoc 174, 727-733.
23. Issel, C. J., Horohov, D. W., Lea, D. F., Adams, W. V., Hagius, S. D., McManus, J. M., Allison, A. C. & Montelaro, R. C. (1992). Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol 66, 3398-3408.
24. Leroux, C., Issel, C. J. & Montelaro, R. C. (1997). Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J Virol 71, 9627-9639.
25. Li, F., Craigo, J. K., Howe, L., Steckbeck, J. D., Cook S., Issel, C. & Montelaro, R. C. (2003). A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. J Virol 77, 7244-7253.
26. Lichtenstein, D. L., Rushlow, K. E., Cook, R. F., Raabe, M. L., Swardson, C. J., Kociba, G. J., Issel, C. J. & Montelaro, R. C. (1995). Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J Virol 69, 2881-2888.
27. McGuire, T. C., Crawford, T. B. & Henson, J. B. (1971). Immunofluorescent localization of equine infectious anemia virus in tissue. Am J Pathol 62, 283-294.
28. McGuire, T. C., Tumas, D. B., Byrne, K. M., Hines, M. T., Leib, S. R., Brassfield, A. L., O'Rourke, K. I. & Perryman, L. E. (1994). Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J Virol 68, 1459-1467.
29. McGuire, T. C., Zhang, W., Hines, M. T., Henney, P. J. & Byrne, K. M. (1997). Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. Virology 238, 85-93.
30. Mealey, R. H., Zhang, B., Leib, S. R., Littke, M. H. & McGuire, T. C. (2003). Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus. Virology 313, 537-552.
31. Mealey, R. H., Sharif, A., Ellis, S. A., Littke, M. H., Leib, S. R. & McGuire, T. C. (2005). Early detection of dominant Env-specific and subdominant Gag-specific CD8 + lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/ peptide tetrameric complexes. Virology 339, 110-126.
32. Montelara, R. C., Ball, J. M. & Rushlow, K. E. (1993). Equine retroviruses. In The Retroviridae, pp. 257-360. Edited by J. A. Levy. New York: Plenum Press.
33. O'Rourke, K., Perryman, L. E. & McGuire, T. C. (1988). Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus. J Gen Virol 69, 667-674.
34. Perryman, L. E., O'Rourke, K. & McGuire, T. C. (1988). Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J Virol 62, 3073-3076.
35. Raabe, M. L., Issel, C. J., Cook, S. J., Cook, R. F., Woodson, B. & Montelaro, R. C. (1998). Immunization with a recombinant envelope protein (rgp9O) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement. Virology 245, 151-162.
36. Ridgely, S. L., Zhang, B. & McGuire, T. C. (2003). Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge. Vaccine 21, 491-506.
37. Roederer, M. & Koup, R. A. (2003). Optimized determination of T cell epitope responses. J Immunol Methods 274, 221-228.
38. Rwambo, P. M., Issel, C. J., Hussain, K. A. & Montelaro, R. C. (1990). In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Arch Virol 111, 275-280.
39. Sarkar, S., Kalia, V., Murphey-Corb, M. & Montelaro, R. C. (2002). Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope. J Immunol 168, 4001-4011.
40. Wang, S. Z. S., Rushlow, K. E., Issel, C. J., Cook, R. F., Cook S. J., Raabe, M. L., Chong, Y. H., Costa, L. & Montelaro, R. C. (1994). Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199, 247-251.
41. Zhang, W., Lonning, S. M. & McGuire, T. C. (1998). Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J Virol 72, 9612-9620.